Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-24 @ 4:02 PM
NCT ID:
NCT04365166
Eligibility Criteria:
Inclusion Criteria:
* Patient admitted to intensive care unit with confirmed SARS-CoV2 infection
* Patient older than 18 years old
Exclusion Criteria:
* Patient coming from another intensive care unit after more than 5 days in the intensive care unit
* Known immunosuppression:
* Known or suspected HIV
* Known or suspected immunosuppression :
* Organ transplantation
* Marrow transplant
* Congenital deficit
* Received immunosuppressive therapy within 30 days (azathioprine, methotrexate, tacrolimus, cyclosporine, sirolimus, cyclophosphamide, rituximab, anti-TNF, JAK inhibitors, corticosteroids \>10mg/day over the last 30 days, recent covid-19 corticosteroid therapy \>1mg/kg prednisolone or equivalent \>5 days)
* Administration of chemotherapy within the last 3 months
* Current pregnancy or breastfeeding
* Patient under 18 years of age
* Incapacitated adults and persons deprived of their liberty
* Refusal by the patient or his/her support person
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04365166
Study Brief:
Protocol Section:
NCT04365166